Arivin Therapeutics raised €3.0M in a Seed round in Sep 2025. The company is based in Helsinki, Finland. Investors in the round: Business Finland, Michiel Seerden. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €3.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
